Form D · Biotechnology

Demetrix, Inc.

Berkeley, CA · CIK 0001716211

Offering snapshot reported Feb 10, 2021 · SEC filing

Reported sold
$50M
Offering amount: $50.5M
Investors reported
16
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 7, 2019
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$25M$50MJul 11, 2019: $19,799,997.00Jul 11, 2019Jul 10, 2020: $30,910,975.00Jul 10, 2020Feb 10, 2021: $49,999,948.00Feb 10, 2021

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$30,910,975 → $49,999,948

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 10, 2021Amendment$49,999,948$19,088,973vs Jul 10, 202016SEC filing
Jul 10, 2020Amendment$30,910,975$11,110,978vs Jul 11, 201916SEC filing
Jul 11, 2019Initial$19,799,997No comparison3SEC filing
Jan 7, 2019Amendment$8,994,997$4,000,000vs Jan 8, 20188SEC filing
Jan 8, 2018Amendment$4,994,997$994,997vs Sep 6, 20178SEC filing
Sep 6, 2017Initial$4,000,000No comparison2SEC filing

Offering details

Securities
Equity, Other
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-344040
Sale and issuance of Series A preferred stock and the underlying shares of Common Stock issuable upon the conversion thereof

Source: Form D, filed Feb 10, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Cynthia Bryant Executive
William Haseltine Director
Jay Keasling Director
Darren Platt Executive
Marc Riiska Director
Jeff Ubersax Executive
Jeffrey Ubersax Director, Executive
Haorui Zhang Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2929 7th Street, Suite 130
Berkeley, CA, 94710